Aclaris Therapeutics ACRS Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Aclaris Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aclaris Therapeutics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aclaris Therapeutics's quick ratio?
- Aclaris Therapeutics (ACRS) reported quick ratio of 4× in Q1 2026.
- How has Aclaris Therapeutics's quick ratio changed year-over-year?
- Aclaris Therapeutics's quick ratio decreased by 20.4% year-over-year, from 5.1× to 4×.
- What is the long-term trend for Aclaris Therapeutics's quick ratio?
- Over 5 years (2020 to 2025), Aclaris Therapeutics's quick ratio has grown at a -2.7% compound annual growth rate (CAGR), from 3.9× to 3.4×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.